SFM
OVID icon

Sphera Funds Management’s Ovid Therapeutics OVID Stock Holding History

Sphera Funds Management’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.6M Buy
+1,622,828
New +$2.9M 0.57% 61
2018
Q1 		– Sell
-180,674
Closed -$1.78M – 131
2017
Q4 		$1.78M Sell
180,674
-125,000
-41% -$1.15M 0.21% 99
2017
Q3 		$2.62M Hold
305,674
– – 0.37% 72
2017
Q2 		$3.04M Buy
+305,674
New +$3.99M 0.52% 60

Other funds holding OVID

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Sphera Funds Management's OVID Position: Q1 2026 in Review

Sphera Funds Management opened a new position in Ovid Therapeutics (OVID) in Q1 2026: 1,622,828 shares worth $3.6M. The stake represents 0.57% of the portfolio and ranks #61 among its holdings. This is a return to the name: Sphera Funds Management previously reported a position in OVID as recently as Q4 2017.

Sphera Funds Management first reported a position in OVID in Q2 2017 and has held it in 4 quarters since. 103 funds tracked by Wall St. Rank hold OVID as of Q1 2026.

  • Sphera Funds Management held 1,622,828 shares of Ovid Therapeutics worth $3.6M as of Q1 2026.
  • Ovid Therapeutics was a new Sphera Funds Management position in Q1 2026.
  • Ovid Therapeutics made up 0.57% of Sphera Funds Management's portfolio in Q1 2026, its #61 holding.
  • Sphera Funds Management first reported a position in Ovid Therapeutics in Q2 2017 and has held it in 4 quarters since.
  • 103 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q1 2026.

Based on Sphera Funds Management's 13F filing for Q1 2026, filed 15 May 2026.